23 Mar 2017 | 4:43 AM
 

Caplin Point Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 524742 | NSE Symbol: CAPLIPOINT
387.50
-2.75
(-0.70 %)
22 Mar 2017 | 03:45 PM
Change company
  • Open (Rs)
    385.50
  • Prev. close (Rs.)
    390.25
  • High (Rs.)
    393.00
  • Low (Rs.)
    384.00
  • 52W H (Rs.)
    1,471.00
  • 52W L (Rs.)
    285.00
  • Volume (Rs.)
    2933
  • MCap (Rs in Cr.)
    2,927.57
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
30.29
Operating Margin (%)
26.80
Gross Profit Margin (%)
23.66
Net Profit Margin (%)
19.17
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
23.84
Earning Retention Ratio
76.16

News

10 Feb 2016 - 17:21:00-Pharma major Caplin Point Laboratories Ltd on Wednesday said its Nomination and Remuneration Committ...
21 Aug 2015 - 17:38:00-Pharma major Caplin Point Laboratories Ltd reported a jump of 81...
09 Jul 2015 - 12:28:00-Drug maker Caplin Point Laboratories Ltd on Thursday said it has received its first EU GMP approval ...
03 Jul 2015 - 11:42:00-Caplin Point Laboratories Ltd has informed in a filing to BSE that it has been selected under Forbes...

Announcements

10-Feb-2017
Caplin Point Lab - Allotment of Equity Shares
06-Feb-2017
Caplin Point Lab - Standalone & Consolidated Financial Results Limited Review Report for December 31 2016
12-Jan-2017
Caplin Point Lab - Board Meeting Intimation for Results & Closure of Trading Window
09-Jan-2017
Caplin Point Lab - Shareholding for the Period Ended December 31 2016
06-Jan-2017
Caplin Point Lab - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Decemb

Religare Research

22 Mar 2017 | 12:00 PM
Agri Fundamental and Technical report
22 Mar 2017 | 09:53 AM
The Indian rupee rose for a second day against the dollar, a sixth day of gain in seven sessions, as...
22 Mar 2017 | 09:34 AM
• Gold glittered as dollar tumbled • Oil fell as market discounted OPEC output cut extension talk • ...
22 Mar 2017 | 07:00 AM
We reiterate our bullish view on markets and suggest continuing with buy on dips approach. Nifty has...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors69.09%
Mutual Funds/UTI0.07%
FI/Banks0.35%
Insurance0.35%
FII4.55%
Government0.00%
Others3.03%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,523.85(0.44)
3280
 Pfizer Ltd.
1,766.75(0.69)
3370
 Dr. Lal Pathlabs Ltd.
936.10(-0.52)
17140
 Wockhardt Ltd.
729.70(0.29)
3787

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Caplin Point Laboratories Ltd.-23.9040.10-923.25
NIFTY(S&P CNX)103.551,051.35163.00
BSE SENSEX302.973,188.08394.55
BSE 500165.521,584.13396.20

Corporate Details

Key Personal
C C Paarthipan
Chairman
D Sathyanarayanan
Addnl.Non Exe.Independent Director
M Jayapal
Whole Time Director
Key Address
Registered Office
Narbavi No. 3 Lakshmanan Street T Nagar,Chennai (Madras),Tamil Nadu

Tel:044-28156653 28156905 45929100 28156901, Fax:044-28154952

investor@caplinpoint.net
http://www.caplinpoint.net
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Caplin Point Laboratories Ltd. that will help you decide whether to buy, sell or hold Caplin Point Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Caplin Point Laboratories Ltd.